Own the gold standard ✨ in financial data & analytics

Subscribe for $2
Overview
Profile
Formosa Laboratories - Stock

Formosa Laboratories Stock

4746.TW
TW0004746003

Price

101.50
Today +/-
+0
Today %
+0 %
P

Formosa Laboratories Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Formosa Laboratories, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Formosa Laboratories from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Formosa Laboratories’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Formosa Laboratories. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Formosa Laboratories’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Formosa Laboratories’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Formosa Laboratories’s growth potential.

Formosa Laboratories Revenue, EBIT and net profit per share

DateFormosa Laboratories RevenueFormosa Laboratories EBITFormosa Laboratories Net Income
2025e5.8 B undefined1.35 B undefined1.15 B undefined
2024e5.13 B undefined891.99 M undefined630.48 M undefined
20234.36 B undefined674.98 M undefined126.24 M undefined
20223.77 B undefined163.49 M undefined409.36 M undefined
20213.14 B undefined-168.02 M undefined1.25 B undefined
20203.08 B undefined28.01 M undefined400.03 M undefined
20192.76 B undefined24.44 M undefined11.63 M undefined
20182.69 B undefined60.48 M undefined176.82 M undefined
20172.54 B undefined378.2 M undefined238.65 M undefined
20163.19 B undefined663.42 M undefined483.44 M undefined
20152.6 B undefined325.57 M undefined282.39 M undefined
20142.5 B undefined273.95 M undefined262.5 M undefined
20132.47 B undefined-75 M undefined-69.4 M undefined
20122.52 B undefined37 M undefined5 M undefined
20112.63 B undefined243.9 M undefined231.1 M undefined
20102.51 B undefined321.3 M undefined246.6 M undefined
20091.9 B undefined252.8 M undefined225.9 M undefined
20082.04 B undefined220.6 M undefined219.1 M undefined
20071.71 B undefined154.7 M undefined142.4 M undefined
20061.36 B undefined134.6 M undefined110.1 M undefined

Formosa Laboratories Stock Ratios

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
2006200720082009201020112012201320142015201620172018201920202021202220232024e2025e
1.361.712.041.92.512.632.522.472.52.63.192.542.692.763.083.143.774.365.135.8
-25.7719.67-7.1431.984.79-3.85-2.020.934.0122.84-20.385.832.6811.452.1819.8315.8017.5713.13
14.2913.1718.5425.2923.8322.2915.4913.7127.4831.0139.4239.5834.0229.9030.7330.9036.9244.11--
0.190.230.380.480.60.590.390.340.690.811.261.010.910.830.950.971.391.9200
0.130.150.220.250.320.240.04-0.080.270.330.660.380.060.020.03-0.170.160.670.891.35
9.879.0210.7613.2812.819.261.47-3.0310.9412.5220.7914.892.230.870.91-5.354.3315.4617.3823.31
0.110.140.220.230.250.230.01-0.070.260.280.480.240.180.010.41.250.410.130.631.15
-29.0954.232.749.33-6.10-97.84-1,480.00-479.717.6371.28-50.72-26.05-93.753,536.36212.25-67.25-69.19400.0082.38
--------------------
--------------------
35.936.348.260.462.267.768.471.791.3695.6495.2196.43102.44100.34118.2121.5120.88120.4900
- - - - - - - - - - - - - - - - - - - -
Details

Keystats

ⓘ

Revenue and Growth

The Formosa Laboratories Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Formosa Laboratories is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Formosa Laboratories provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Formosa Laboratories's financial health and stability.

Assets

Formosa Laboratories's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Formosa Laboratories must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Formosa Laboratories after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Formosa Laboratories's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20062007200820092010201120122013201420152016201720182019202020212022
0.110.140.220.230.250.230.01-0.060.310.340.610.310.15-0.040.361.090.33
47456281106119133150193231265283318384449474470
2910-10910-40000000000
-86-62-124126-247-38010-98-243-345207-201-488-109-31-5-35
013211-71725382025242-5755-304-1,246-125
022133918172022161237181917
13206627322221156085150506103521
0.10.140.180.450.1-0.010.170.030.280.261.110.4-0.080.290.480.310.64
-40-54-86-263-435-373-494-559-468-402-461-473-1,000-1,421-1,011-513-439
-43-54-86-271-456-502-835-673-529-473-569-642-1,049-1,480-860-589-540
-300-8-20-128-340-113-60-71-107-169-48-58150-75-100
00000000000000000
-0-0.01-0-0.20.560.251.080.30.240.4-0.440.631.090.820.01-0.090.42
000175047405000000300034300
-0.07-0.08-0.12-0.130.370.490.850.80.240.23-0.610.521.380.770.520.440.45
-7-7-902400-10001511760161531271
-64-64-105-107-210-234-23400-168-174-267-186-4900-240
-152-255316-26181157-814-71271253-417127148549
60.483.292.9190.9-335.5-385-323.8-527.6-188.14-147.19648.51-77.74-1,081.86-1,131.36-536.19-202.66203.1
00000000000000000

Formosa Laboratories stock margins

The Formosa Laboratories margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Formosa Laboratories. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Formosa Laboratories.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Formosa Laboratories's sales revenue. A higher gross margin percentage indicates that the Formosa Laboratories retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Formosa Laboratories's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Formosa Laboratories's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Formosa Laboratories's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Formosa Laboratories. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Formosa Laboratories's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Formosa Laboratories Margin History

Formosa Laboratories Gross marginFormosa Laboratories Profit marginFormosa Laboratories EBIT marginFormosa Laboratories Profit margin
2025e44.11 %23.31 %19.83 %
2024e44.11 %17.4 %12.3 %
202344.11 %15.48 %2.9 %
202236.92 %4.34 %10.87 %
202130.91 %-5.35 %39.75 %
202030.73 %0.91 %13.01 %
201929.91 %0.89 %0.42 %
201834.01 %2.25 %6.58 %
201739.61 %14.89 %9.4 %
201639.43 %20.8 %15.16 %
201531.04 %12.54 %10.87 %
201427.51 %10.97 %10.52 %
201313.72 %-3.03 %-2.81 %
201215.5 %1.47 %0.2 %
201122.29 %9.29 %8.8 %
201023.86 %12.82 %9.84 %
200925.33 %13.32 %11.9 %
200818.55 %10.79 %10.72 %
200713.18 %9.05 %8.33 %
200614.33 %9.91 %8.1 %

Formosa Laboratories Stock Sales Revenue, EBIT, Earnings per Share

The Formosa Laboratories earnings per share therefore indicates how much revenue Formosa Laboratories has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Formosa Laboratories earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Formosa Laboratories's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Formosa Laboratories’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Formosa Laboratories's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Formosa Laboratories Revenue, EBIT and net profit per share

DateFormosa Laboratories Sales per ShareFormosa Laboratories EBIT per shareFormosa Laboratories Earnings per Share
2025e48.22 undefined0 undefined9.56 undefined
2024e42.63 undefined0 undefined5.24 undefined
202336.19 undefined5.6 undefined1.05 undefined
202231.15 undefined1.35 undefined3.39 undefined
202125.86 undefined-1.38 undefined10.28 undefined
202026.02 undefined0.24 undefined3.38 undefined
201927.5 undefined0.24 undefined0.12 undefined
201826.24 undefined0.59 undefined1.73 undefined
201726.33 undefined3.92 undefined2.47 undefined
201633.5 undefined6.97 undefined5.08 undefined
201527.15 undefined3.4 undefined2.95 undefined
201427.32 undefined3 undefined2.87 undefined
201334.5 undefined-1.05 undefined-0.97 undefined
201236.9 undefined0.54 undefined0.07 undefined
201138.78 undefined3.6 undefined3.41 undefined
201040.29 undefined5.17 undefined3.96 undefined
200931.43 undefined4.19 undefined3.74 undefined
200842.41 undefined4.58 undefined4.55 undefined
200747.07 undefined4.26 undefined3.92 undefined
200637.85 undefined3.75 undefined3.07 undefined

Formosa Laboratories business model

Formosa Laboratories, Inc. is a renowned company in the field of research and development, pharmaceuticals, and diagnostics, operating in the industry for over 30 years. Founded in 1989, the company has become one of the leading providers of innovative solutions and products that allow its customers to improve their healthcare and enhance their quality of life. The business model of Formosa Laboratories is focused on meeting the high demands of its customers. The company works closely with medical professionals, scientists, and researchers to develop products that meet the needs of patients. With an experienced and diverse team of experts in areas such as research and development, quality control, production, marketing, and sales, Formosa Laboratories is able to offer fast and effective solutions for all customer requirements. The company has divided its various business areas into different divisions, each specialized in different areas of medicine and diagnostics. The three main business divisions are research and development, pharmaceuticals, and diagnostics. In the field of research and development, the company offers services such as preclinical research, biologics research, and development strategies. The company is dedicated to researching new control procedures and technologies to ensure the effectiveness of its solutions. Formosa Laboratories takes pride in its innovative research and development team, which stays up to date with the latest technology and continuously develops new products to meet the needs of its customers. In the pharmaceutical field, the company offers a wide range of prescription and non-prescription medications prescribed by doctors around the world. Formosa Laboratories relies on close collaboration with its customers to ensure that each patient receives the best possible medical care. The company is committed to manufacturing high-quality and safe medications. In the field of diagnostics, the company offers a variety of diagnostic tests and kits that allow for accurate and fast diagnosis of various diseases and conditions. With advanced technology and precise test results, Formosa Laboratories helps doctors and medical professionals make quick and accurate diagnoses to start treatment as soon as possible. Over the years, Formosa Laboratories has developed numerous products that have improved people's lives and fought against diseases. Some of the company's well-known products include: - Influenza Rapid Tests: A fast and accurate test for diagnosing the flu. - Pregnancy Test Kits: A traditional pregnancy test that is able to confirm or exclude pregnancy in a woman. - Needle-free Syringes: An innovation that allows for medication injection without a needle. In conclusion, Formosa Laboratories Inc is a significant company in the medical and diagnostics industry, dedicated to manufacturing high-quality and safe products. With its experienced and qualified team, the company is able to offer fast and effective solutions tailored to the individual needs of its customers. Formosa Laboratories is one of the most popular companies on Eulerpool.com.

Formosa Laboratories SWOT Analysis

Strengths

Formosa Laboratories Inc has a strong track record of delivering high-quality pharmaceutical products to the market. Their well-established reputation for excellence has garnered trust from customers and partners alike.

The company boasts a highly skilled and experienced team of professionals who consistently contribute to the innovation and development of new drugs. Formosa Laboratories Inc's robust research and development capabilities enable them to stay competitive in the rapidly-evolving pharmaceutical industry.

Weaknesses

Despite their strengths, Formosa Laboratories Inc faces certain weaknesses. One of the notable weaknesses is their limited geographical presence. The company primarily operates within a specific region, which may hinder their potential for expansion and global market reach.

Another weakness is the company's heavy reliance on a few key suppliers. This dependency poses risks in terms of supply chain disruptions and potential price fluctuations, which can impact manufacturing and distribution activities.

Opportunities

The pharmaceutical industry is continuously growing, presenting numerous opportunities for Formosa Laboratories Inc. The increasing global demand for healthcare products, advancements in technology, and emerging markets offer potential for expansion and diversification.

Furthermore, strategic collaborations and partnerships with other healthcare companies can provide avenues for expanding their product portfolio and accessing new markets. Formosa Laboratories Inc can leverage these opportunities to enhance their market position and profitability.

Threats

Formosa Laboratories Inc faces various external threats that could impact their business operations. Intense competition from both established pharmaceutical companies and emerging players poses challenges in terms of market share and pricing pressures.

Additionally, stringent regulatory requirements and evolving regulations in the pharmaceutical industry can increase compliance burdens and add complexities to the product development and approval process.

Formosa Laboratories valuation based on historical P/E ratio, EBIT, and P/S ratio.

Formosa Laboratories shares outstanding

The number of shares was Formosa Laboratories in 2023 — This indicates how many shares 120.491 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Formosa Laboratories earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Formosa Laboratories's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Formosa Laboratories’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Formosa Laboratories's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Formosa Laboratories Stock Dividend

In 2023, Formosa Laboratories paid a dividend amounting to 1 TWD. Dividend means that Formosa Laboratories distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Formosa Laboratories provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Formosa Laboratories’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Formosa Laboratories's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Formosa Laboratories Dividend History

DateFormosa Laboratories Dividend
2025e0.99 undefined
2024e0.97 undefined
20231 undefined
20222 undefined
20190.49 undefined
20181.97 undefined
20172.84 undefined
20161.95 undefined
20151.96 undefined
20123.4 undefined
20113.4 undefined
20103.4 undefined

Formosa Laboratories Stock Payout Ratio

In 2023, Formosa Laboratories had a payout ratio of 162.63%. The payout ratio indicates the percentage of the company's profits that Formosa Laboratories distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Formosa Laboratories represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Formosa Laboratories could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Formosa Laboratories's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Formosa Laboratories Payout Ratio History

DateFormosa Laboratories Payout ratio
2025e123.94 %
2024e150.14 %
2023162.63 %
202259.06 %
2021228.72 %
2020200.11 %
2019427 %
2018114.26 %
2017114.89 %
201638.44 %
201566.29 %
2014200.11 %
2013200.11 %
20124,852.38 %
201199.32 %
201085.77 %
2009200.11 %
2008200.11 %
2007200.11 %
2006200.11 %
Unfortunately, there are currently no price targets and forecasts available for Formosa Laboratories.

Formosa Laboratories Earnings Surprises

DateEPS EstimateEPS ActualQuarterly report
3/31/20240.83 -0.8  (-196.83 %)2024 Q1
12/31/20232.83 1.52  (-46.3 %)2023 Q4
9/30/20230.69 -0.95  (-236.97 %)2023 Q3
6/30/20231.04 0.69  (-33.9 %)2023 Q2
3/31/20230.84 -0.21  (-125.11 %)2023 Q1
12/31/202213.44 2.71  (-79.84 %)2022 Q4
9/30/20190.61 1.54  (154.88 %)2019 Q3
6/30/2019-0.05 -1.19  (-2,252.38 %)2019 Q2
3/31/20190.69 0.31  (-55.63 %)2019 Q1
12/31/20180.12 1  (724.97 %)2018 Q4
1
2
3
4

Formosa Laboratories Stock Shareholders

%
Name
Stocks
Change
Date
6.44 % Cheng (Cheng Yu)7,744,00008/31/2023
4.58 % Cathay Securities Investment Trust Co., Ltd.5,508,0005,508,00012/31/2023
3.02 % Japan Securities Finance Co Ltd3,631,00008/31/2023
2.55 % Lee (Hsiu Hui-a)3,068,00008/31/2023
2.22 % Mo Lo Jia Investment Company Ltd.2,674,00008/31/2023
2.07 % Cathay Life Insurance Co., Ltd.2,493,00008/31/2023
2.02 % Ding Li Development Company Ltd.2,433,00008/31/2023
1.95 % JPMorgan Asset Management (Taiwan) Limited2,343,00008/31/2023
1.74 % Mega International Investment Trust Co., Ltd.2,087,0001,061,00012/31/2023
1.61 % Dimensional Fund Advisors, L.P.1,940,731-16,0002/29/2024
1
2

Formosa Laboratories stock: Frequently Asked Questions

What values and corporate philosophy does Formosa Laboratories represent?

Formosa Laboratories Inc represents a set of core values and a corporate philosophy. The company is committed to delivering high-quality pharmaceutical products to meet healthcare needs. With a focus on innovation, Formosa Laboratories Inc employs advanced technologies and research capabilities to develop safe and effective medications. The company is dedicated to operating with integrity, transparency, and ethical practices in all aspects of its business. Formosa Laboratories Inc strives to continuously improve and enhance its services, fostering strong partnerships and trust with customers and stakeholders.

In which countries and regions is Formosa Laboratories primarily present?

Formosa Laboratories Inc primarily operates in Taiwan and has a strong presence in various countries and regions within the Asia-Pacific region. As a leading pharmaceutical company, Formosa Laboratories Inc serves the local Taiwanese market with its advanced manufacturing facilities and research and development capabilities. Additionally, the company has successfully expanded its business to neighboring regions such as China, Hong Kong, and Southeast Asian countries. With a focus on delivering high-quality healthcare products, Formosa Laboratories Inc continues to establish itself as a prominent player in the pharmaceutical industry across the Asia-Pacific markets.

What significant milestones has the company Formosa Laboratories achieved?

Formosa Laboratories Inc has achieved several significant milestones throughout its operation. One notable achievement is its successful entry into the global market, expanding its presence beyond domestic boundaries. Additionally, the company has continuously fostered innovation, leading to the development of cutting-edge pharmaceutical products and advanced manufacturing processes. Formosa Laboratories Inc has also garnered recognition for its commitment to quality, receiving various certifications and accolades for its excellence in manufacturing standards. Moreover, the company has built strong partnerships with renowned global pharmaceutical firms, further validating its industry expertise and capabilities. These milestones highlight Formosa Laboratories Inc's continuous pursuit of growth, innovation, and international prominence.

What is the history and background of the company Formosa Laboratories?

Formosa Laboratories Inc is a renowned pharmaceutical company with a rich history and background. Founded in [year], Formosa Laboratories Inc has established itself as a leader in the industry. The company specializes in [specifics of their products/services]. Over the years, Formosa Laboratories Inc has expanded its operations, ensuring high-quality products and innovative solutions. With a dedicated team of experts, the company has successfully gained a strong foothold in the market. Formosa Laboratories Inc continues to strive for excellence, constantly adapting to meet the evolving needs of its customers. With a remarkable track record, Formosa Laboratories Inc stands as a trusted and reliable name in the pharmaceutical sector.

Who are the main competitors of Formosa Laboratories in the market?

The main competitors of Formosa Laboratories Inc in the market include companies such as Company A, Company B, and Company C. These companies compete with Formosa Laboratories Inc in the industry by offering similar products or services. These competitors pose a challenge to Formosa Laboratories Inc's market share and profitability. However, Formosa Laboratories Inc has been able to differentiate itself through its unique offerings, quality products, and excellent customer service, enabling it to maintain a strong position in the market.

In which industries is Formosa Laboratories primarily active?

Formosa Laboratories Inc is primarily active in the pharmaceutical industry.

What is the business model of Formosa Laboratories?

The business model of Formosa Laboratories Inc revolves around providing contract research, development, and manufacturing services to the pharmaceutical industry. As a leading player in the market, Formosa Laboratories Inc offers a comprehensive range of solutions, including formulation development, analytical development, clinical trial material manufacturing, and commercial manufacturing. With a strong focus on quality and innovation, the company aims to support its clients in bringing safe and effective drugs to the market. Formosa Laboratories Inc's expertise, state-of-the-art facilities, and commitment to meeting regulatory standards make it a trusted partner in the pharmaceutical sector.

What is the P/E ratio of Formosa Laboratories 2024?

The Formosa Laboratories P/E ratio is 19.4.

What is the P/S ratio of Formosa Laboratories 2024?

The Formosa Laboratories P/S ratio is 2.39.

What is the AlleAktien quality score of Formosa Laboratories?

The AlleAktien quality score for Formosa Laboratories is 5/10.

What is the revenue of Formosa Laboratories 2024?

The expected Formosa Laboratories revenue is 5.13 B TWD.

How high is the profit of Formosa Laboratories 2024?

The expected Formosa Laboratories profit is 630.48 M TWD.

What is the business model of Formosa Laboratories

Formosa Laboratories Inc. is a leading company in the pharmaceutical and biotechnological industry. The company specializes in the development and manufacturing of drugs, the analysis of preclinical and clinical studies, and the production of biotechnology products. The company has been a major player in the pharmaceutical market since its founding in 2006 and is headquartered in Taipei, Taiwan.

What is the Formosa Laboratories dividend?

Formosa Laboratories pays a dividend of 2 TWD distributed over payouts per year.

How often does Formosa Laboratories pay dividends?

The dividend cannot currently be calculated for Formosa Laboratories or the company does not pay out a dividend.

What is the Formosa Laboratories ISIN?

The ISIN of Formosa Laboratories is TW0004746003.

What is the Formosa Laboratories ticker?

The ticker of Formosa Laboratories is 4746.TW.

How much dividend does Formosa Laboratories pay?

Over the past 12 months, Formosa Laboratories paid a dividend of 1 TWD . This corresponds to a dividend yield of about 0.99 %. For the coming 12 months, Formosa Laboratories is expected to pay a dividend of 0.99 TWD.

What is the dividend yield of Formosa Laboratories?

The current dividend yield of Formosa Laboratories is 0.99 %.

When does Formosa Laboratories pay dividends?

Formosa Laboratories pays a quarterly dividend. This is distributed in the months of August, September, August, September.

How secure is the dividend of Formosa Laboratories?

Formosa Laboratories paid dividends every year for the past 4 years.

What is the dividend of Formosa Laboratories?

For the upcoming 12 months, dividends amounting to 0.99 TWD are expected. This corresponds to a dividend yield of 0.97 %.

In which sector is Formosa Laboratories located?

Formosa Laboratories is assigned to the 'Health' sector.

Wann musste ich die Aktien von Formosa Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Formosa Laboratories from 9/22/2023 amounting to 1 TWD, you needed to have the stock in your portfolio before the ex-date on 8/24/2023.

When did Formosa Laboratories pay the last dividend?

The last dividend was paid out on 9/22/2023.

What was the dividend of Formosa Laboratories in the year 2023?

In the year 2023, Formosa Laboratories distributed 2 TWD as dividends.

In which currency does Formosa Laboratories pay out the dividend?

The dividends of Formosa Laboratories are distributed in TWD.

Other fundamentals and analyses of Formosa Laboratories in the deep dive.

Our stock analysis for Formosa Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Formosa Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.